FSC
UTHR icon

Full Sail Capital’s United Therapeutics UTHR Stock Holding History

Full Sail Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$252K Buy
+601
New +$202K 0.01% 262

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Full Sail Capital's UTHR Position: Q3 2025 in Review

Full Sail Capital opened a new position in United Therapeutics (UTHR) in Q3 2025: 601 shares worth $252K. The stake represents 0.01% of the portfolio and ranks #262 among its holdings.

708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Full Sail Capital held 601 shares of United Therapeutics worth $252K as of Q3 2025.
  • United Therapeutics was a new Full Sail Capital position in Q3 2025.
  • United Therapeutics made up 0.01% of Full Sail Capital's portfolio in Q3 2025, its #262 holding.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Full Sail Capital's 13F filing for Q3 2025, filed 14 Nov 2025.